Patent Filing Considerations in View of Revised EU Clinical Trial Regulation Transparency Rules
The transparency requirements of the EU Clinical Trials Regulation present a complex intellectual property challenge requiring a nuanced approach to patent protection of clinical trial-related inventions.
In collaboration with DLRC, a leading Regulatory Affairs Consultancy, we’ve developed a whitepaper outlining key patent filing considerations. Authored by Karen Ng, and James Biddlecombe (Business Transformation & CTR Lead at DLRC Regulatory Consultancy), this paper emphasises the importance of early and ongoing collaboration between legal and regulatory teams throughout the life cycle of clinical trials to optimise patent filing opportunities.
Download the Whitepaper